Delivery Order SPE2DB24D3014-SPE2DB24FKSFB
Award Date
9/13/24
Potential Completion Date
10/4/24
Potential Value
$13K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,670.90 firm fixed-price delivery order is for the supply of PROQUAD VIALS, a pharmaceutical product. The contract has an ultimate completion date of July 16, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract, valued at $9,423.24, is for the delivery of PROQUAD VIALS, a pharmaceutical product, with an ultimate completion date of September 18, 2024. The contract has a firm fixed price pricing type and is not set aside for any specific business category. AmerisourceBergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $1,575.60 firm fixed price delivery order is for the supply of PROQUAD VIALS, a pharmaceutical product. The contract has a completion date of February 27, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,012.70 firm fixed-price delivery order is for PROQUAD VIALS, with a completion date of June 12, 2025. The contract is not set aside and represents an order under Amerisourcebergen's $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides global pharmaceutical support to...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $9,585.87 Firm Fixed Price Delivery Order is for the supply of 4565051179 PROQUAD VIALS, with an ultimate completion date of July 12, 2024. Amerisourcebergen is a major pharmaceutical distribution company that leverages its extensive supply chain to fulfill government contracts, particularly with the Department of Defense (DoD) and...
This federal contract award, valued at $1,687.48, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of PROQUAD VIALS. The contract has an ultimate completion date of April 23, 2025 and is a Firm Fixed Price Delivery Order. The contract does not have a set-aside designation. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,601.99, is a Firm Fixed Price Delivery Order for the supply of PROQUAD VIALS, a medical product. The award has an ultimate completion date of November 18, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of PROQUAD VIALS. The $3,203.98 Firm Fixed Price Delivery Order has an ultimate completion date of August 20, 2024. AmerisourceBergen holds a broader Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025 for delivering a range of medical commodities to support military...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $3,203.98 delivery order contract is for the supply of PROQUAD VIALS, a pharmaceutical product, with a performance completion date of July 26, 2024. The contract is a firm fixed-price type with no set-aside designation. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of PROQUAD VIALS, a pharmaceutical product, with a potential value of $6,717.91. The contract is a firm fixed price delivery order with a completion date of March 12, 2024. Amerisourcebergen Drug Corp holds an...